Abstract
Positive salt and water balance with persistently elevated blood pressure (BP) leads to increased cardiovascular (CV) mortality in patients with End stage renal disease (ESRD) on chronic hemodialysis (HD). Apart from dietary sodium, the high dialysate sodium during dialysis also contributes to sodium gain. The adjustment of dialysate sodium has a potential to achieve euvolemia and control BP. We conducted a prospective crossover trial to investigate the effect of individualized dialysate sodium compared to standard uniform dialysate sodium on interdialytic weight gain (IDWG) and control of BP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
